Why the study?
Dexmedetomidine possesses analgesic effects with a different mechanism of action than opioids, prompting an in-depth review of its use in ERAS protocols for clinical anesthesiologists.
Does dexmedetomidine improve postoperative pain and recovery outcomes in patients undergoing surgery with ERAS protocols?
Design
Review
Authors
Loading...
May support dexmedetomidine in ERAS protocols; leaves open prospective validation versus ropivacaine.
Does dexmedetomidine improve postoperative pain and recovery outcomes in patients undergoing surgery with ERAS protocols?
Dexmedetomidine serves as a valuable analgesic adjunct in ERAS protocols, improving postoperative pain control and facilitating earlier recovery.
Kaye et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: